You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-SET antibodySee all SET primary antibodies ...
  • Description
    Rabbit polyclonal to SET
  • Tested applicationsWB, IP more details
  • Species reactivity
    Reacts with: Chicken, Human
  • Immunogen

    Synthetic peptide, corresponding to a region within amino acids 125-175 (VTEFEDIKSG YRIDFYFDEN PYFENKVLSK EFHLNESGDP SSKSTEIKWK S) of Human SET, (NP_001116293.1).

  • Positive controlHeLa and 293T cell lysate

Properties

Applications

Our Abpromise guarantee covers the use of ab92872 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB
IP
  • Application notesIP: Use at 3-5µg/mg of lysate.
    WB: 1/2000 - 1/10000. Predicted molecular weight: 33 kDa.


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionMultitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone binding. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1. In the course of cytotoxic T-lymphocyte (CTL)-induced apoptosis, GZMA cleaves SET, disrupting its binding to NME1 and releasing NME1 inhibition. Isoform 1 and isoform 2 are potent inhibitors of protein phosphatase 2A. Isoform 1 and isoform 2 inhibit EP300/CREBBP and PCAF-mediated acetylation of histones (HAT) and nucleosomes, most probably by masking the accessibility of lysines of histones to the acetylases. The predominant target for inhibition is histone H4. HAT inhibition leads to silencing of HAT-dependent transcription and prevents active demethylation of DNA. Both isoforms stimulate DNA replication of the adenovirus genome complexed with viral core proteins; however, isoform 2 specific activity is higher.
    • Tissue specificityWidely expressed. Low levels in quiescent cells during serum starvation, contact inhibition or differentiation. Highly expressed in Wilms' tumor.
    • Involvement in diseaseNote=A chromosomal aberration involving SET is found in some cases of acute undifferentiated leukemia (AUL). Translocation t(6;9)(q21;q34.1) with NUP214/CAN.
    • Sequence similaritiesBelongs to the nucleosome assembly protein (NAP) family.
    • DomainThe C-terminal acidic domain mediates the inhibition of histone acetyltransferases and is required for the DNA replication stimulatory activity.
    • Post-translational
      modifications
      Isoform 2 is phosphorylated on Ser-15 and Thr-23.
      Isoform 2 is acetylated on Lys-11.
      Some glutamate residues are glycylated by TTLL8. This modification occurs exclusively on glutamate residues and results in a glycine chain on the gamma-carboxyl group.
      N-terminus of isoform 1 is methylated by METTL11A/NTM1. Mainly trimethylated.
    • Cellular localizationCytoplasm > cytosol. Endoplasmic reticulum. Nucleus > nucleoplasm. In the cytoplasm, found both in the cytosol and associated with the endoplasmic reticulum. Following CTL attack, moves rapidly to the nucleus, where it is found in the nucleoplasm, avoiding the nucleolus. Similar translocation to the nucleus is also observed for lymphocyte-activated killer cells after the addition of calcium. The SET complex is associated with the endoplasmic reticulum.
    • Target information above from: UniProt accession Q01105 The UniProt Consortium
      The Universal Protein Resource (UniProt) in 2010
      Nucleic Acids Res. 38:D142-D148 (2010) .

      Information by UniProt
    • Database links
    • Alternative names
        2PP2A antibodyHLA DR associated protein II antibodyHLA-DR-associated protein II antibody
        I 2PP2A antibodyI-2PP2A antibodyI2PP2A antibodyIGAAD antibodyInhibitor of granzyme A activated DNase antibodyInhibitor of granzyme A-activated DNase antibodyPHAPII antibodyPhosphatase 2A inhibitor I2PP2A antibodyProtein SET antibodySet antibodySET translocation antibodySET translocation (myeloid leukemia-associated) antibodySET_HUMAN antibodyTAF I antibodyTAF IBETA antibodyTAF-I antibodyTAFI antibodyTemplate activating factor I antibodyTemplate-activating factor I antibody
      see all

    Anti-SET antibody images

    • All lanes : Anti-SET antibody (ab92872) at 0.04 µg/ml

      Lane 1 : HeLa cell lysate at 50 µg
      Lane 2 : HeLa cell lysate at 15 µg
      Lane 3 : HeLa cell lysate at 5 µg
      Lane 4 : 293T cell lysate at 50 µg

      developed using the ECL technique

      Predicted band size : 33 kDa


      Exposure time : 30 seconds
    • 3µg ab92872 were used to immunoprecipitate SET from 1mg HeLa whole cell lysate. 20% IP was loaded and probed with ab92872 at 1µg/ml.
    • Anti-SET antibody (ab92872) at 1/2000 dilution ((in 3% milk in PBST). Incubation was for 24 hours at 4°C.) + Lysate of the soluble fraction of HwLa or U20S cells at 30 µg

      Secondary
      An HRP polymer Goat anti-rabbit IgG polyclonal at 1/10000 dilution
      developed using the ECL technique

      Predicted band size : 33 kDa
      Observed band size : ~37,~40 kDa (why is the actual band size different from the predicted?)


      Exposure time : 1 minute

      This image is courtesy of an anonymous Abreview

      See Abreview

    References for Anti-SET antibody (ab92872)

    ab92872 has not yet been referenced specifically in any publications.

    Product Wall

    Filter by Application

    Filter by Species

    Filter by Ratings

    Abreviews
    Application Western blot
    Sample Chicken Cell lysate - other (Chicken lymphoblasts DT40)
    Loading amount 30 µg
    Specification Chicken lymphoblasts DT40
    Gel Running Conditions Reduced Denaturing (10%)
    Blocking step Milk as blocking agent for 30 minute(s) · Concentration: 5% · Temperature: rt°C
    Username

    Verified customer

    Submitted Jul 19 2010

    Abreviews
    Application Western blot
    Sample Human Cell lysate - other (Soluble Fraction (HeLa or U2OS))
    Loading amount 30 µg
    Specification Soluble Fraction (HeLa or U2OS)
    Gel Running Conditions Reduced Denaturing (10%)
    Blocking step Milk as blocking agent for 30 minute(s) · Concentration: 5% · Temperature: rt°C
    Username

    Verified customer

    Submitted Jun 16 2010

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"